Teva Pharmaceutical Industries Aktie
WKN: 883035 / ISIN: US8816242098
03.04.2024 14:25:47
|
UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma
(RTTNews) - Biotech company UroGen Pharma Ltd. (URGN) announced Wednesday that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd. (TEVA), alleging infringement of U.S. Patent Numbers 9,040,074 and 9,950,069.
Both patents are listed in the U.S. Food and Drug Administration's (FDA) Approved Drug Products with Therapeutic Equivalence Evaluations for JELMYTO (mitomycin) for pyelocalyceal solution.
JELMYTO is indicated for the treatment of adults with low-grade, upper tract urothelial cancer and utilizes UroGen's RTGel reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology.
The lawsuit follows an Abbreviated New Drug Application filed by Teva Pharmaceuticals, Inc., which seeks authorization from the FDA to manufacture, use or sell a generic version of mitomycin for pyelocalyceal solution, 40 mg/vial in the United States before the expiry of the '074 and '069 patents.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)mehr Nachrichten
30.09.25 |
NASDAQ Composite-Handel aktuell: NASDAQ Composite schlussendlich mit positivem Vorzeichen (finanzen.at) | |
30.09.25 |
Handel in New York: NASDAQ Composite nachmittags in Rot (finanzen.at) | |
30.09.25 |
Dienstagshandel in New York: NASDAQ Composite am Dienstagmittag leichter (finanzen.at) | |
26.09.25 |
NASDAQ Composite Index-Titel Teva Pharmaceutical Industries-Aktie: So viel Gewinn hätte eine Investition in Teva Pharmaceutical Industries von vor einem Jahr abgeworfen (finanzen.at) | |
19.09.25 |
NASDAQ Composite Index-Papier Teva Pharmaceutical Industries-Aktie: So viel Verlust hätte ein Investment in Teva Pharmaceutical Industries von vor 10 Jahren bedeutet (finanzen.at) | |
15.09.25 |
Montagshandel in New York: NASDAQ Composite zum Ende des Montagshandels in Grün (finanzen.at) | |
15.09.25 |
Pluszeichen in New York: NASDAQ Composite nachmittags freundlich (finanzen.at) | |
15.09.25 |
NASDAQ Composite aktuell: Gewinne im NASDAQ Composite (finanzen.at) |
Analysen zu UroGen Pharma Ltd Registered Shsmehr Analysen
Aktien in diesem Artikel
Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 17,00 | 0,00% |
|
UroGen Pharma Ltd Registered Shs | 16,60 | 3,75% |
|